MedTrace Logo

Progesterone Treatment of Blunt Traumatic Brain Injury

NCT00048646 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2014-09-19

No results posted yet for this study

Summary

The purpose of this study is to determine if progesterone treatment safely reduces brain swelling and damage after injury.

Conditions

Interventions

DRUG

IV Progesterone

Sponsors & Collaborators

  • National Institute of Neurological Disorders and Stroke (NINDS)

    collaborator NIH

  • David Wright

    lead OTHER

Principal Investigators

  • Arthur L Kellermann, MD, MPH · Chairman - Emory University Dept. of Emergency Medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2002-05-31
Primary Completion
2005-09-30
Completion
2005-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00048646 on ClinicalTrials.gov